Hematologic disorders comprise a vast category of diseases that affect millions of Americans and have a significant impact on the lives of individuals, their loved ones and the U.S. healthcare system ...

Research on palliative care for blood cancers has surged in recent years, yet a new large-scale mapping study reveals ...

Background: The US Department of Veterans Affairs (VA) National Oncology Program (NOP) has established a standard for veteran-focused cancer care across the Veterans Health Administration. This ...

The US Food and Drug Administration (FDA) issued draft guidance Monday to describe a “streamlined nonclinical program” aimed at aiding sponsors with the development of drugs used for treating severely ...

Hematology oncology focuses on diagnosing and treating cancers of the blood, bone marrow, and lymphatic system. You might be ...

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women ...

The US Food and Drug Administration (FDA) on Thursday finalized guidance on the nonclinical studies drugmakers should conduct when developing products to treat severely debilitating or ...

Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola virus disease (EVD) and are characterized by one or several abnormalities in ...

Anemia is a common hematological disorder that requires timely diagnosis to reduce the risk of severe health complications, particularly in resource-limited healthcare settings. This study proposes ...